REGENXBIO Inc.
Organization details
- Legal name
- REGENXBIO Inc.
- Former names
- ReGenX Biosciences, LLC
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Headquarters city
- Rockville
- Headquarters state / province
- Maryland
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- RGNX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001590877
- EIN
- 47-1851754
Board of directors
-
Alexandra Glucksmann · DirectorSince 2023
-
Allan M. Fox · DirectorSince 2023
-
Argeris N. Karabelas · DirectorSince 2023
-
Curran Simpson · Director · Chief Executive OfficerSince 2024
-
Daniel Tasse · DirectorSince 2023
-
David C. Stump · DirectorSince 2023
-
George Migausky V · DirectorSince 2023
-
Gregory Austin Ciongoli · DirectorSince 2026
-
Jean Bennett · DirectorSince 2023
-
Jennifer Zachary · DirectorSince 2023
-
Kenneth T. Mills · Director · President and CEOSince 2023
Chief executives
Director election results
Annual meeting of May 29, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
68.1%
-
90.9%
Board connections
5 of this board's directors also sit on 7 other boards. 7 are in the same sector.
-
Atara Biotherapeutics Inc. Same sectorvia Gregory Austin Ciongoli
-
DBV Technologies S.A. Same sectorvia Daniel Tasse
-
Gossamer Bio Inc. Same sectorvia Gregory Austin Ciongoli
-
Immunovant Inc. Same sectorvia George Migausky V
-
MacroGenics Inc. Same sectorvia David C. Stump
-
Opus Genetics Inc. Same sectorvia Jean Bennett
-
Zymeworks Inc. Same sectorvia Gregory Austin Ciongoli
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $949,541
- 2 purchases by 1 insider
- Sold, last 12 months
- $939,970
- 5 sales by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 1, 2026 | Mitchell Chan Officer (Chief Financial Officer) | Grant or award | +24,305 | — | — |
| Nov 1, 2026 | Christmas Patrick J. Officer (Chief Strategy & Legal Officer) | Grant or award | +34,722 | — | — |
| Nov 1, 2026 | Malzahn Craig Officer (Chief Technology Officer) | Grant or award | +27,777 | — | — |
| Nov 1, 2026 | PAKOLA STEVE Officer (Chief Medical Officer) | Grant or award | +34,722 | — | — |
| Sep 1, 2026 | Mitchell Chan Officer (Chief Financial Officer) | Shares withheld for tax | −4,902 | $9.32 | $45,687 |
| Sep 1, 2026 | Malzahn Craig Officer (Chief Technology Officer) | Shares withheld for tax | −234 | $9.32 | $2,181 |
| Aug 27, 2026 | Gregory Austin Ciongoli Director | Open-market purchase | +53,407 | $9.36 | $499,890 |
| Aug 26, 2026 | Gregory Austin Ciongoli Director | Open-market purchase | +49,196 | $9.14 | $449,651 |
| Aug 25, 2026 | Gregory Austin Ciongoli Director | Grant or award | +15,432 | — | — |
| Aug 1, 2026 | Christmas Patrick J. Officer (Chief Strategy & Legal Officer) | Shares withheld for tax | −4,699 | $9.69 | $45,533 |
| Aug 1, 2026 | PAKOLA STEVE Officer (Chief Medical Officer) | Shares withheld for tax | −7,468 | $9.69 | $72,365 |
| Jul 2, 2026 | PAKOLA STEVE Officer (Chief Medical Officer) | Option exercise | +2,161 | $7.86 | $16,985 |
| Jul 2, 2026 | PAKOLA STEVE Officer (Chief Medical Officer) | Open-market sale | −2,161 | $13.64 | $29,476 |
| Jul 1, 2026 | PAKOLA STEVE Officer (Chief Medical Officer) | Option exercise | +36,725 | $7.86 | $288,659 |
| Jul 1, 2026 | PAKOLA STEVE Officer (Chief Medical Officer) | Open-market sale | −36,725 | $12.86 | $472,284 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about REGENXBIO Inc.
Who is the CEO of REGENXBIO Inc.?
Kenneth T. Mills is REGENXBIO Inc.'s President and CEO.
How many directors are on REGENXBIO Inc.'s board?
REGENXBIO Inc.'s board has 11 directors: Alexandra Glucksmann, Allan M. Fox, Argeris N. Karabelas, Curran Simpson, Daniel Tasse, David C. Stump, George Migausky V, Gregory Austin Ciongoli, Jean Bennett, Jennifer Zachary and 1 other.
Are REGENXBIO Inc. insiders buying or selling shares?
Over the last 12 months, REGENXBIO Inc. insiders bought $949,541 of shares in 2 purchases and sold $939,970 of shares in 5 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="regenxbio-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.